Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Yeh SW
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=3.217
------>paper_class3=2
------>paper_class2=1
------>vol=120
------>confirm_bywho=cmbwrlee
------>insert_bywho=yehsw
------>Jurnal_Rank=31.3
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=75
------>medlineContent=
------>unit=E0118
------>insert_date=20070429
------>iam=1
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=1521-6616
------>authors_c=
------>score=89
------>journal_name=Clin Immunol
------>paper_name=Pathogenic Human Monoclonal Antibody Against Desmoglein 3
------>confirm_date=20070503
------>tch_id=095046
------>pmid=17532189
------>page1=68
------>fullAbstract=BACKGROUND: Although pemphigus vulgaris (PV)-IgG has been shown to activate urokinase plasminogen activator (uPA) in cultured keratinocytes, activation of uPA is thought to have no primary role in PV-acantholysis, because PV-IgG is still pathogenic in uPA- and tissue-PA-knockout mice. OBJECTIVE: To determine if PV-IgG-induced uPA activation is due to specific antibody against Dsg3, we examined whether or not pathogenic monoclonal anti-Dsg3 antibody can activate uPA, because PV-IgG is thought to contain antibodies against unknown antigens besides Dsg3. METHODS: We stimulated cultured normal human and DJM-1 keratinocytes with monoclonal anti-Dsg3 IgG1 antibodies (pathogenic AK23, AK19 and nonpathogenic AK18, AK20), negative control monoclonal mouse IgG1 and positive control PV-IgG. Cells were treated with IgGs over a time course of 24h, and uPA-protein content and activity in the culture medium were determined by enzyme-linked immunosorbent assay (ELISA) and chromogenic assay, respectively. RESULTS: The uPA-protein content in samples treated with or without pathogenic, nonpathogenic, control monoclonal mouse IgG1s and PV-IgGs increased continuously up to 24h, with no differences between samples, suggesting a spontaneous secretion. In contrast, uPA activity in the culture medium of cells treated with PV-IgG increased dramatically, whereas that of cells treated with all AK-IgGs and control monoclonal mouse IgG1 did not increase at all. CONCLUSION: These results suggest that PV-IgG-dependent uPA activation is not related to anti-Dsg3 antibody activity, which is an essential factor in PV-IgG acantholysis, and that it may be due to other antigens than Dsg3 or unknown factors contained in PV-IgG fraction.
------>tmu_sno=None
------>sno=15245
------>authors2=Cavacini LA
------>authors3=Bhol KC
------>authors4=Lin MS
------>authors5=Kumar M
------>authors6=Duval M, [Posner MR, Ahmed AR]
------>authors6_c=
------>authors=Yeh SW
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=1
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2006
------>submit_flag=None
------>publish_month=7
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z